Clinical significance of pathogenic variants in germline <i>BRCA</i> wild type patients at risk for hereditary breast cancer.

Xiaying Kuang; Jing Liu; Ying Lin; Shuyin Chen; Nan Shao; Zhen Shan; Hao Liu; Liang Yu; Xinyi Shi

doi:10.1200/jco.2019.37.15_suppl.e13127

Clinical significance of pathogenic variants in germline <i>BRCA</i> wild type patients at risk for hereditary breast cancer.

Xiaying Kuang(Sun Yat-sen University), Jing Liu(Fujian Medical University), Ying Lin(Sun Yat-sen University), Shuyin Chen(Guangdong Medical College), Nan Shao(The First People's Hospital of Changzhou), Zhen Shan(Shenyang Medical College), Hao Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Liang Yu(Sun Yat-sen University), Xinyi Shi(Shandong University of Traditional Chinese Medicine)

Journal of Clinical Oncology

May 20, 2019

10.1200/jco.2019.37.15_suppl.e13127

Cited by 0

|Molecular Cancer|2017|413

Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance

|Nature Communications|2021|358

Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment

|JAMA|2020|229

Methamphetamine and Other Substance Use During Pregnancy: Preliminary Estimates From the Infant Development, Environment, and Lifestyle (IDEAL) Study

|Maternal and Child Health Journal|2006|221

Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases

|Nature Communications|2018|193

Clinical significance of pathogenic variants in germline <i>BRCA</i> wild type patients at risk for hereditary breast cancer.

Related Papers